Why did BIIB.SW stock fall pre-market on 05 Mar 2026?

The pre-market fall to CHF143.90 (-37.97%) reflects headline risk and repositioning ahead of earnings. Low pre-market volume on SIX magnifies gaps. Expect news and earnings to drive follow-through trading.

What is Meyka AI's forecast for BIIB.SW stock?

Meyka AI's forecast model projects **CHF189.88** in one year for BIIB.SW stock. That implies a **31.95%** upside from CHF143.90. Forecasts are model-based projections and not guarantees.

What key ratios should investors watch for BIIB.SW stock?

Watch EPS **6.80**, P/E near **21.69**, P/B **1.20**, and current ratio **2.50**. Also monitor cash per share **14.94** CHF and debt/equity **0.37** to judge liquidity and leverage.

When is Biogen's next earnings and how will it affect BIIB.SW stock?

Biogen's next earnings announcement is scheduled for 06 May 2026. Earnings and guidance will likely move BIIB.SW stock sharply, given current volatility and pipeline sensitivity.

CH Stocks

Biogen (BIIB.SW, SIX) -37.97% pre-market 05 Mar 2026: valuation and outlook

ByHuzaifa Zahoor March 5, 2026March 5, 2026

BIIB.SW stock opened pre-market at CHF143.90 on 05 Mar 2026, down 37.97% from yesterday’s close. The move makes Biogen Inc. one of the top losers on the SIX this morning. Traders are reacting to headline risk and repositioning ahead of the company earnings date. Meyka AI, an AI-powered market analysis platform, flags the drop as notable given Biogen’s mixed valuation metrics and pipeline exposure.